SCHEDULE 13G/A: ARK Investment Management Discloses 3.99% Stake in Adaptive Biotechnologies
Beneficial Ownership Report
ARK Investment Management LLC has filed an amended Schedule 13G, reporting a beneficial ownership of 3.99% in Adaptive Biotechnologies Corporation as of April 30, 2025.
Summary
- ARK Investment Management LLC reported beneficial ownership of 6,067,809 shares of Common Stock in Adaptive Biotechnologies Corporation.
- This stake represents 3.99% of the total class of securities.
- The filing indicates that ARK Investment Management LLC, an Investment Adviser, holds sole voting power and sole dispositive power over all 6,067,809 shares.
- The securities were acquired and are held in the ordinary course of business, and not for the purpose of changing or influencing the control of Adaptive Biotechnologies Corporation.
Sentiment
Score: 5
Explanation: The document is a factual disclosure of beneficial ownership and does not contain information that would inherently convey positive or negative sentiment regarding the issuer's performance or prospects. It simply reports an institutional stake.
Future Outlook
NA
Industry Context
This filing is a standard disclosure of institutional ownership and does not provide specific industry context for Adaptive Biotechnologies Corporation beyond identifying it as a publicly traded company in which an investment adviser has taken a significant stake.
Stakeholder Impact
- Shareholders: Disclosure of a significant institutional investor's stake provides transparency regarding the ownership structure and may influence investor perception and trading activity.
Key Dates
| Date | Description |
|---|---|
| 04/30/2025 | Date of event which required the filing of this statement |
| 05/07/2025 | Date of filing and signature by ARK Investment Management LLC |
Keywords
Adaptive Biotechnologies, ARK Investment Management, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing, Institutional Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.